How to initiate EU Paediatric Plans – Regulatory Strategy & Writing

October 21, 2020
  • Drug Development

Our experts at BlueReg are covering the different aspects of the Paediatric Plan, specific to the European Market.

The different subjects covered are :


1. Regulatory Strategy


  • Why do we need an EU Paediatric Plan?
  • Is a PIP required?
  • Plan the PIP procedure
  • Overview of the PIP procedure
  • Which PIP condition?
  • Should the PIP include a paediatric development, a waiver and/or a deferral?
  • Content of the PIP Application


2. Writing the Paediatric Scientific Document


  • Application Summary
  • Overall Development
  • Product-Specific Waiver(s)
  • Paediatric Investigation Plan
  • Deferral(s)
  • References


3. Q&A’s




Access the Full Webinar and the slide deck

    By sending this form, I agree that my personal data will be saved and processed according to data protection regulations and will be used only for commercial and marketing purposes only.

    Learn more

    BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
    Any inquiries, correction or declaration of event related to personal data processed should be sent to: GDPR data request

    GDPR data request

    Thank you! You can watch the webinar now.

    Download your document